Cedars-Sinai Viral Vector Core (VVC) was established in 2011 to serve the viral vector production needs of Cedars-Sinai researchers. We are located on the eighth floor of the Advanced Health Sciences Pavilion (A8504) at the Regenerative Medicine Institute. Currently, standard and custom vector production services are available for both lenti and first generation adenoviral vectors.
New users are highly encouraged to discuss vector requirements with VVC Director, Dr. Vaithi Arumugaswami. Investigators planning to use viral vectors and recombinant DNA should obtain the approval of the Institutional Biosafety Committee (IBC) and other regulatory agencies prior to commencement of experiments.